CLINICAL CASE OF RARE TYPE V OSTEOGENESIS IMPERFECTA

Osteogenesis imperfecta, also known as the brittle bone disease, is a clinically heterogenic hereditary connective tissue disease characterized by brittle bones and high risk of skeletal bone fractures. Other observable symptoms, such as deformities of limb and spinal bones, blue sclerae, dentinogenesis imperfecta and progressive hearing loss vary in severity depending on the type of the disease. According to the original classification by D.O. Silence (1979), there are 4 types of osteogenesis imperfecta; however, the number thereof has multiplied due to discovery of new disease-inducing mutations. Type V osteogenesis imperfecta is distinguished by characteristic clinical radiographic symptoms; also, patients with this type of the disease do not feature a type I collagen gene mutation. Nevertheless, all types of osteogenesis imperfecta, including type V, are characterized by high bone brittleness, frequent fractures and further bone deformities, which is the most common cause of incapacitation of the patients.

osteogenesis imperfecta, pseudosarcoma, bone fracture, fibrocartilage callus, densitometry, bisphosphonate, bone brittleness, alphacalcidol, IFITM5, BRIL, children

1. Sillence D.O., Senn A., Danks D.M. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet. 1979 Apr; 16 (2): 101–116.

2. Sillence D.O., Barlow K.K., Garber A.P., Hall J.G., Rimoin D.L. Osteogenesis imperfecta type II delineation of the phenotype with reference to genetic heterogeneity. Am J Med Genet. 1984 Feb; 17 (2): 407−23.

3. Glorieux F.H., Rauch F., Plotkin H., Ward L., Travers R., Roughley P., Lalic L., Glorieux D.F., Fassier F., Bishop N.J. Type V osteogenesis imperfecta: a new form of brittle bone disease. J Bone Miner Res. 2000 Sep; 15 (9): 1650−8.

4. Cheung M.S., Azouz E.M., Glorieux F.H., Rauch F. Hyperplastic callus formation in osteogenesis imperfecta type V: follow-up of three generations over ten years. Skeletal Radiology. 2008 May, 37 (Issue 5): 465−467.

5. Cheung M.S., Glorieux F.H., Rauch F. Natural History of Hyperplastic Callus Formation in Osteogenesis Imperfecta Type V. Journal of Bone and Mineral Research. 2007; 22 (8): 1181–1186.

6. Fassier A.M., Rauch F., Aarabi M., Janelle C., Fassier F. Radial head dislocation and subluxation in osteogenesis imperfecta. J Bone Joint Surg Am. 2007 Dec; 89 (12): 2694−704.

7. Oliver Semler, Lutz Garbes, Katharina Keupp, Daniel Swan, Katharina Zimmermann, Jutta Becker, Sandra Iden, Brunhilde Wirth, Peer Eysel, Friederike Koerber, Eckhard Schoenau, Stefan K. Bohlander, Bernd Wollnik, Christian Netzer. A Mutation in the 5′-UTR of IFITM5 Creates an In-Frame Start Codon and Causes Autosomal-Dominant Osteogenesis Imperfecta Type V with Hyperplastic Callus. Am J Hum Genet. 2012 Aug 10; 91 (2): 349−57. Doi: 10.1016/j.ajhg.2012.06.011. Epub 2012 Aug 2.

8. Hanagata N., Li X., Morita H., Takemura T., Li J., Minowa T. Characterization of the osteoblast-specific transmembrane protein IFITM5 and analysis of IFITM5-deficient mice. J Bone Miner Metab. 2011 May; 29 (3): 279−90. Doi: 10.1007/s00774-010-0221-0. Epub 2010 Sep 14.

9. Hanagata N., Li X. Osteoblast-enriched membrane protein IFITM5 regulates the association of CD9 with an FKBP11-CD81-FPRP complex and stimulates expression of interferon-induced genes. Biochem Biophys Res Commun. 2011 Jun 10; 409 (3): 378−84. Doi: 10.1016/j.bbrc.2011.04.136. Epub 2011 May 11.

10. Grover M., Campeau P.M., Lietman C.D., Lu J.T., Gibbs R.A., Schlesinger A.E., Lee B.H. Osteogenesis imperfect without features of type V caused by a mutation in the IFITM5 gene. J Bone Miner Res. 2013 Nov; 28 (11): 2333−7. Doi: 10.1002/jbmr.1983.